EP 2473622 A1 20120711 - PROGNOSTIC MOLECULAR SIGNATURE OF SARCOMAS, AND USES THEREOF
Title (en)
PROGNOSTIC MOLECULAR SIGNATURE OF SARCOMAS, AND USES THEREOF
Title (de)
PROGNOSTISCHE MOLEKULARE SIGNATUR VON SARKOMEN SOWIE VERWENDUNGEN DAVON
Title (fr)
SIGNATURE MOLÉCULAIRE PRONOSTIQUE DES SARCOMES ET UTILISATIONS
Publication
Application
Priority
- FR 0901936 A 20090422
- US 17149509 P 20090422
- FR 2010000323 W 20100421
Abstract (en)
[origin: WO2010122243A1] The present invention relates to a prognostic molecular signature for sarcomas, and in particular for genetically complex sarcomas, and to the use thereof for predicting the overall survival of a patient, particularly for predicting the appearance of metastases but also for differentiating prognostically separate sub-groups within a group of tumors having the same histological grade. Said molecular signature can also be used for testing the effectiveness of a treatment or for producing novel therapeutic agents.
IPC 8 full level
C12Q 1/68 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 35/00 (2017.12 - EP); C12Q 1/6886 (2013.01 - EP US); C12Q 2600/118 (2013.01 - EP US); C12Q 2600/136 (2013.01 - EP US); C12Q 2600/158 (2013.01 - EP US)
Citation (search report)
See references of WO 2010122243A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
DOCDB simple family (publication)
WO 2010122243 A1 20101028; CA 2759417 A1 20101028; CA 2759417 C 20180508; EP 2473622 A1 20120711; FR 2944805 A1 20101029; FR 2944805 B1 20180406; JP 2012524537 A 20121018; JP 5865241 B2 20160217; US 2013065772 A1 20130314; US 9708666 B2 20170718
DOCDB simple family (application)
FR 2010000323 W 20100421; CA 2759417 A 20100421; EP 10718241 A 20100421; FR 0901936 A 20090422; JP 2012506544 A 20100421; US 201013265764 A 20100421